These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4104967)

  • 1. The "nose drop nose" due to oxymetazoline (Afrin) and other topical vasoconstrictors.
    Feinberg AR; Feinberg SM
    IMJ Ill Med J; 1971 Jul; 140(1):50-2. PubMed ID: 4104967
    [No Abstract]   [Full Text] [Related]  

  • 2. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A topical nasal decongestant for children.
    Neffson AH
    Eye Ear Nose Throat Mon; 1968 Mar; 47(3):121-3. PubMed ID: 4171734
    [No Abstract]   [Full Text] [Related]  

  • 4. Branch retinal artery occlusion after excessive use of nasal spray.
    Magargal LE; Sanborn GE; Donoso LA; Gonder JR
    Ann Ophthalmol; 1985 Aug; 17(8):500-1. PubMed ID: 2413795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nasal decongestants and eye drops: keep out of children's reach!].
    Poulin-Chartrand S
    Perspect Infirm; 2013; 10(2):63. PubMed ID: 23539872
    [No Abstract]   [Full Text] [Related]  

  • 6. ["Of snakes and crocodiles": central side effects of nose drops and facts about rhinitis medicamentosa].
    Bielenberg J
    Kinderkrankenschwester; 2011 Oct; 30(10):406-8. PubMed ID: 22029138
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a new oxymetazoline preparation in the treatment of nasal congestion. A multicentre trial.
    Practitioner; 1975 May; 214(1283):685-688. PubMed ID: 49890
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical images: Afrin-induced central nervous system vasospasm and thunderclap headache.
    Greene RR
    Arthritis Rheum; 2005 Oct; 52(10):3314. PubMed ID: 16200605
    [No Abstract]   [Full Text] [Related]  

  • 10. Fetal heart rate changes following maternal administration of a nasal decongestant.
    Baxi LV; Gindoff PR; Pregenzer GJ; Parras MK
    Am J Obstet Gynecol; 1985 Dec; 153(7):799-800. PubMed ID: 2416220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal.
    Graf PM; Hallén H
    Am J Rhinol; 1997; 11(1):67-72. PubMed ID: 9065350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradycardia, hypotension, and near-syncope associated with Afrin (oxymetazoline) nasal spray.
    Glazener F; Blake K; Gradman M
    N Engl J Med; 1983 Sep; 309(12):731. PubMed ID: 6888446
    [No Abstract]   [Full Text] [Related]  

  • 13. Physiologic and clinical estimates of the relief of nasal flow obstruction in allergic rhinitis: effects of a topical decongestant (oxymetazoline).
    Cohen BM; Duffy EP
    J Asthma Res; 1969 Dec; 7(2):65-73. PubMed ID: 4189976
    [No Abstract]   [Full Text] [Related]  

  • 14. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray.
    Loewen AH; Hudon ME; Hill MD
    CMAJ; 2004 Sep; 171(6):593-4. PubMed ID: 15367461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-ST-elevation myocardial infarction with the use of oxymetazoline nasal spray.
    Rajpal S; Morris LA; Akkus NI
    Rev Port Cardiol; 2014 Jan; 33(1):51.e1-4. PubMed ID: 24405558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paranasal sinusitis after long-term use of topical nasal decongestants.
    Min YG; Kim HS; Suh SH; Jeon SY; Son YI; Yoon S
    Acta Otolaryngol; 1996 May; 116(3):465-71. PubMed ID: 8790749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new nasal decongestant in otolaryngology.
    Young JR
    Eye Ear Nose Throat Mon; 1967 Jan; 46(1):51-3. PubMed ID: 4166874
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical test of oxymetazoline-HCl-nose drops for infants (Nasivin 0,01 per cent)].
    Rüggeberg F
    Z Allgemeinmed; 1974 Apr; 50(11):535-7. PubMed ID: 4135074
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of oxymetazoline in nasal endoscopic sinus surgery].
    Zhen H; Gao Q; Cui Y; Hua X; Li H; Feng J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 May; 17(5):281-2. PubMed ID: 12916356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.